ライフサイエンスコーパス: obsessive-compulsive

1 es between the disorders included in the new Obsessive-Compulsive and Related Disorders chapter.

2 Obsessive-compulsive and related disorders may be influe

3 The new DSM-5 "Obsessive-Compulsive and Related Disorders" chapter cont

4 OCD is the key example of the 'obsessive-compulsive and related disorders', a group of

5 ased cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders

6 s of cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders

7 iated behaviors, such as poor socialization, obsessive-compulsive behavior, and hyperactivity.

8 included autistic features, mood disorders, obsessive-compulsive behaviors and hetero- and autoaggre

9 o resulted in significantly lower scores for obsessive-compulsive behaviors at 16 weeks.

10 ic protein implicated in the pathogenesis of obsessive-compulsive behaviors.

11 Tics and obsessive-compulsive behaviour (OCB) significantly impro

12 related with improvement in tics or comorbid obsessive-compulsive behaviour and to predict clinical o

13 For obsessive-compulsive behaviour, both targets showed that

14 iated with improvements in tics and comorbid obsessive-compulsive behaviour, compare the networks acr

15 dation, hyperactivity, cognitive impairment, obsessive-compulsive behaviour, seizure activity and aut

16 Obsessive/compulsive behaviours and irritability/aggress

17 atures: depression, irritability/aggression, obsessive/compulsive behaviours, apathy and psychosis.

18 13.9% of the participants, and 13.2% showed obsessive/compulsive behaviours.

19 he hindbrain results in excessive barbering, obsessive compulsive digging and lack of cage exploratio

20 Autism spectrum disorders (ASDs) and obsessive compulsive disorder (OCD) are often comorbid w

21 Obsessive and Compulsive Symptoms (OCS) or Obsessive Compulsive Disorder (OCD) in the context of sc

22 f Default Mode Network (DMN) deactivation in Obsessive Compulsive Disorder (OCD) in the transition be

23 Obsessive compulsive disorder (OCD) is a severe illness

24 ractivity in the CSTC pathway is involved in obsessive compulsive disorder (OCD), a neuropsychiatric

25 f inflexible behavior influenced by anxiety, Obsessive Compulsive Disorder (OCD).

26 tial computational basis for OC symptoms and obsessive compulsive disorder (OCD).

27 ncluding major depressive disorder (MDD) and obsessive compulsive disorder (OCD).

28 s often associated with major depression and obsessive compulsive disorder (OCD).

29 (PFC) and striatum in the neuropathology of obsessive compulsive disorder (OCD).

30 the priest or asipu; other disorders such as obsessive compulsive disorder and psychopathic behaviour

31 llingness to 'walk away', whereas those with obsessive compulsive disorder become more deliberative a

32 Thus, subjects with obsessive compulsive disorder on subthalamic stimulation

33 rols converge with the effective contacts in obsessive compulsive disorder patients localized within

34 sess decisional impulsivity in subjects with obsessive compulsive disorder who have undergone deep br

35 tal illnesses including depression, anxiety, obsessive compulsive disorder, autism and eating disorde

36 ders, including epilepsy, stroke, psychoses, obsessive compulsive disorder, phobias, psychopathic beh

37 f compulsive disorders, such as addiction or obsessive compulsive disorder, remain unknown.

38 Obsessive-compulsive disorder (OCD) affects 2%-3% of the

39 family studies have consistently found that obsessive-compulsive disorder (OCD) aggregates in famili

40 CBT) has been established as efficacious for obsessive-compulsive disorder (OCD) among older children

41 .1 (1.6); the mean number was 0.9 (1.3) when obsessive-compulsive disorder (OCD) and attention-defici

42 Autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD) and attention-defici

43 e also symptomatic of psychopathologies like obsessive-compulsive disorder (OCD) and autism spectrum

44 sights into understanding conditions such as obsessive-compulsive disorder (OCD) and drug addiction;

45 Although the relationship between obsessive-compulsive disorder (OCD) and obsessive-compul

46 ostriatal circuits in the pathophysiology of obsessive-compulsive disorder (OCD) and OC-spectrum diso

47 m is associated with compulsive behaviors in obsessive-compulsive disorder (OCD) and related illnesse

48 Despite a remarkable co-occurrence of obsessive-compulsive disorder (OCD) and schizophrenia, l

49 e examined behavioral alterations related to obsessive-compulsive disorder (OCD) and the role of TNFa

50 ive functioning are present in patients with obsessive-compulsive disorder (OCD) and their first-degr

51 tion has been linked with the development of obsessive-compulsive disorder (OCD) and tic disorders, a

52 ration on perseverative behaviors related to obsessive-compulsive disorder (OCD) and Tourette syndrom

53 Obsessive-compulsive disorder (OCD) and Tourette's syndr

54 The association between obsessive-compulsive disorder (OCD) and Tourette's/chron

55 The DSM provides distinct criteria for obsessive-compulsive disorder (OCD) and various types of

56 t core deficits in goal-directed behavior in obsessive-compulsive disorder (OCD) are caused by impair

57 (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD) are common neurodeve

58 Anorexia nervosa (AN) and obsessive-compulsive disorder (OCD) are often comorbid a

59 Around 7%-10% of patients with obsessive-compulsive disorder (OCD) are refractory to fi

60 M) abnormalities have long been suspected in obsessive-compulsive disorder (OCD) but the available ev

61 n stimulation (DBS) for treatment-refractory obsessive-compulsive disorder (OCD) can be considered an

62 Patients with obsessive-compulsive disorder (OCD) can be described as

63 For a small percentage of obsessive-compulsive disorder (OCD) cases exhibiting add

64 in activation abnormalities in patients with obsessive-compulsive disorder (OCD) during both processe

65 Up to 30% of patients with obsessive-compulsive disorder (OCD) exhibit an inadequat

66 Many children with childhood-onset obsessive-compulsive disorder (OCD) fail to respond adeq

67 n stimulation (DBS) for treatment refractory obsessive-compulsive disorder (OCD) has not been examine

68 ults from structural neuroimaging studies of obsessive-compulsive disorder (OCD) have been only parti

69 Approximately 10% of patients with obsessive-compulsive disorder (OCD) have symptoms that a

70 Select cases of intractable obsessive-compulsive disorder (OCD) have undergone neuro

71 tistical Manual of Mental Disorders (DSM-5), obsessive-compulsive disorder (OCD) included a new "tic-

72 Obsessive-compulsive disorder (OCD) is a chronic and dis

73 Obsessive-compulsive disorder (OCD) is a common, debilit

74 Obsessive-compulsive disorder (OCD) is a debilitating ne

75 Obsessive-compulsive disorder (OCD) is a disabling condi

76 Obsessive-compulsive disorder (OCD) is a disorder of aut

77 Obsessive-compulsive disorder (OCD) is a highly prevalen

78 variants, even when genomic data are limited.Obsessive-compulsive disorder (OCD) is a neuropsychiatri

79 Obsessive-compulsive disorder (OCD) is a neuropsychiatri

80 Obsessive-compulsive disorder (OCD) is a psychiatric con

81 Obsessive-compulsive disorder (OCD) is a psychiatric con

82 Obsessive-compulsive disorder (OCD) is a psychiatric dis

83 Obsessive-compulsive disorder (OCD) is a severe, chronic

84 rovided consistent support for the idea that obsessive-compulsive disorder (OCD) is associated with d

85 Obsessive-compulsive disorder (OCD) is associated with h

86 Obsessive-compulsive disorder (OCD) is associated with i

87 Obsessive-compulsive disorder (OCD) is associated with r

88 Obsessive-compulsive disorder (OCD) is commonly associat

89 tive behavior therapy (CBT) among youth with obsessive-compulsive disorder (OCD) is effective, but ma

90 Development of treatments for obsessive-compulsive disorder (OCD) is hampered by a lac

91 risk of death by suicide in individuals with obsessive-compulsive disorder (OCD) is largely unknown.

92 Obsessive-compulsive disorder (OCD) is prevalent and wit

93 Obsessive-compulsive disorder (OCD) may be characterized

94 The compulsive behaviour underlying obsessive-compulsive disorder (OCD) may be related to ab

95 igation of structural covariance networks in obsessive-compulsive disorder (OCD) may provide clues to

96 te syndrome/chronic tic disorder (TS/CT) and obsessive-compulsive disorder (OCD) overlap in their phe

97 t-degree relatives of these SCZ patients, 13 obsessive-compulsive disorder (OCD) patients, 18 unaffec

98 ed for severe, chronic, treatment-refractory obsessive-compulsive disorder (OCD) patients.

99 oxamine in urine and blood plasma samples of obsessive-compulsive disorder (OCD) patients.

100 Neurobiological models of obsessive-compulsive disorder (OCD) predict hyperactivit

101 -related potential, is a reliable finding in obsessive-compulsive disorder (OCD) research and may be

102 on-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD) share impaired inhib

103 Autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD) share inhibitory con

104 Pediatric obsessive-compulsive disorder (OCD) sometimes appears ra

105 Treatments for obsessive-compulsive disorder (OCD) tend to be of mixed

106 tients with severe, debilitating symptoms of obsessive-compulsive disorder (OCD) that have proven ref

107 netic relationships among Tourette syndrome, obsessive-compulsive disorder (OCD), and attention defic

108 epression is a commonly occurring symptom in obsessive-compulsive disorder (OCD), and is associated w

109 ve disorders (DDs), anxiety disorders (ADs), obsessive-compulsive disorder (OCD), and posttraumatic s

110 ral therapy (CBT) is effective for pediatric obsessive-compulsive disorder (OCD), but non-response is

111 RP) is an effective first-line treatment for obsessive-compulsive disorder (OCD), but only some patie

112 ecognizes hoarding disorder as distinct from obsessive-compulsive disorder (OCD), codifying a new con

113 ogic and cognitive behavioral treatments for obsessive-compulsive disorder (OCD), some patients conti

114 variation has a known impact on the risk for obsessive-compulsive disorder (OCD), there is also evide

115 Stimulated by the ego-dystonic nature of obsessive-compulsive disorder (OCD), where compulsive ac

116 In mice, genetic deletion of Sapap3 causes obsessive-compulsive disorder (OCD)-like behaviors that

117 tability in the thalamocortical circuits and obsessive-compulsive disorder (OCD)-like grooming behavi

118 ons to striatal dysfunction in the Sapap3-KO obsessive-compulsive disorder (OCD)-relevant mouse model

119 moval dysfunction similar to humans with the obsessive-compulsive disorder (OCD)-spectrum disorder, t

120 reatment option for patients with refractory obsessive-compulsive disorder (OCD).

121 e neuronal glutamate transporter EAAC1, with obsessive-compulsive disorder (OCD).

122 nown about whether this is also the case for obsessive-compulsive disorder (OCD).

123 natal complications may increase the risk of obsessive-compulsive disorder (OCD).

124 or patients with severe treatment-refractory obsessive-compulsive disorder (OCD).

125 rocessing, both of which are associated with obsessive-compulsive disorder (OCD).

126 based cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD).

127 n techniques for the treatment of refractory obsessive-compulsive disorder (OCD).

128 cortex is implicated in the neurobiology of obsessive-compulsive disorder (OCD).

129 spatial learning in unmedicated adults with obsessive-compulsive disorder (OCD).

130 n be used to accelerate genomic discovery in obsessive-compulsive disorder (OCD).

131 l correlates of excessive habit formation in obsessive-compulsive disorder (OCD).

132 st robust psychophysiological alterations in obsessive-compulsive disorder (OCD).

133 ential processing in unmedicated adults with obsessive-compulsive disorder (OCD).

134 tions thought to be etiologically related to obsessive-compulsive disorder (OCD).

135 ort treatment for severe treatment-resistant obsessive-compulsive disorder (OCD).

136 on (DBS) is an emerging treatment for severe obsessive-compulsive disorder (OCD).

137 VCVS) DBS in both major depression (MDD) and obsessive-compulsive disorder (OCD).

138 rst-line pharmacological agents for treating obsessive-compulsive disorder (OCD).

139 n cohort; it did not predict the severity of obsessive-compulsive disorder (R(2) = .11%, p empirical

140 [ADHD], autism spectrum disorder [ASD], and obsessive-compulsive disorder [OCD]) share genetic vulne

141 Fifteen patients with obsessive-compulsive disorder and 15 healthy control vol

142 that compulsive behaviors, characteristic of obsessive-compulsive disorder and addiction, are driven

143 ers with impaired decision-making, including obsessive-compulsive disorder and addiction.

144 er of neuropsychiatric conditions, including obsessive-compulsive disorder and addiction.

145 able from healthy individuals in depression, obsessive-compulsive disorder and attention-deficit hype

146 on in disorders as diverse as schizophrenia, obsessive-compulsive disorder and autism, and suggests t

147 ders are common and are suggested to include obsessive-compulsive disorder and behaviours, attention

148 iatric disorders that include schizophrenia, obsessive-compulsive disorder and bipolar disorder (BD).

149 ment current models of symptom generation in obsessive-compulsive disorder and may enable the develop

150 al anterior limb of the internal capsule for obsessive-compulsive disorder and possibly other psychia

151 ded for some mental health disorders such as obsessive-compulsive disorder and post-traumatic stress

152 e heritability of major depressive disorder, obsessive-compulsive disorder and schizophrenia within t

153 omorbidities, including anxiety, depression, obsessive-compulsive disorder and schizophrenia, are fre

154 onin reuptake inhibitors for childhood-onset obsessive-compulsive disorder and the anxiety disorders,

155 ction in neuropsychiatric conditions such as obsessive-compulsive disorder and Tourette syndrome rema

156 ngulotomy and capsulotomy for depression and obsessive-compulsive disorder are considered 'establishe

157 Obsessive-compulsive disorder clusters in families prima

158 In contrast, patients with obsessive-compulsive disorder had slower processing spee

159 nterventions are available for management of obsessive-compulsive disorder in adults, but few studies

160 ements for 608 genes potentially involved in obsessive-compulsive disorder in human, dog, and mouse.

161 alcohol use disorders in nonblack women, and obsessive-compulsive disorder interacted with drug use d

162 Obsessive-compulsive disorder is a chronic psychiatric d

163 s a biological basis that schizophrenia with obsessive-compulsive disorder is a distinct subtype of s

164 Deep brain stimulation for obsessive-compulsive disorder is a rapidly developing tr

165 Obsessive-compulsive disorder is a severe and disabling

166 Obsessive-compulsive disorder is a severe psychiatric di

167 A striking observation in obsessive-compulsive disorder is that patients know that

168 Obsessive-compulsive disorder is treated with exposure w

169 Obsessive-compulsive disorder patients exhibit a pattern

170 Obsessive-compulsive disorder patients, compared with co

171 Obsessive-compulsive disorder patients, compared with si

172 le study of posttraumatic stress disorder or obsessive-compulsive disorder to date, although there is

173 hifts evidence accumulation in subjects with obsessive-compulsive disorder towards a functional less

174 14-week randomized clinical trial (Pediatric Obsessive-Compulsive Disorder Treatment Study for Young

175 tients (13 female) with treatment-refractory obsessive-compulsive disorder undergoing deep brain stim

176 Obsessive-compulsive disorder was eight times more likel

177 sorder, bipolar disorder, schizophrenia, and obsessive-compulsive disorder were highly correlated (r

178 Multiple surgical targets for treating obsessive-compulsive disorder with deep brain stimulatio

179 as, panic, generalized anxiety disorder, and obsessive-compulsive disorder), substance use disorder (

180 major depressive disorder, 0.6% vs. 7.1% for obsessive-compulsive disorder, 2.5% vs. 6.7% for panic d

181 d a 69% (95% CI, 46%-94%) increased risk for obsessive-compulsive disorder, a 21% (95% CI, 11%-33%) i

182 proach for patients with treatment-resistant obsessive-compulsive disorder, a condition linked to abn

183 al phobia, specific phobia, agoraphobia, and obsessive-compulsive disorder, all dimensional scores us

184 umans for the treatment of major depression, obsessive-compulsive disorder, and addiction, may also b

185 ia, bipolar disorder, depression, addiction, obsessive-compulsive disorder, and anxiety), we found th

186 ression, post-traumatic stress disorder, and obsessive-compulsive disorder, and determine whether any

187 been associated with Tourette's syndrome and obsessive-compulsive disorder, and dysfunction of cortic

188 emerge: (1) anorexia nervosa, schizophrenia, obsessive-compulsive disorder, and education years are n

189 inson's disease, essential tremor, dystonia, obsessive-compulsive disorder, and epilepsy, chronic ele

190 s conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol d

191 raumatic stress disorder, anxiety disorders, obsessive-compulsive disorder, and substance use disorde

192 e amygdala circuit in the pathophysiology of obsessive-compulsive disorder, and suggest a neural syst

193 nxiety disorder, agoraphobia, social phobia, obsessive-compulsive disorder, anorexia, or substance ab

194 tal regions in the etiology and treatment of obsessive-compulsive disorder, anxiety, and depression,

195 among others, major depressive disorder and obsessive-compulsive disorder, arguably characterized by

196 y-onset neurodevelopmental disorders such as obsessive-compulsive disorder, attention deficit hyperac

197 chronicity of tics, and symptom severity of obsessive-compulsive disorder, attention-deficit/hyperac

198 e disorder, bipolar disorder, schizophrenia, obsessive-compulsive disorder, autism spectrum disorders

199 toms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, o

200 erventions is effective in the management of obsessive-compulsive disorder, but considerable uncertai

201 n effective treatment for therapy-refractory obsessive-compulsive disorder, but its effect on dopamin

202 rders, aggressiveness and violence in crime, obsessive-compulsive disorder, depression, suicide, schi

203 s including depression, Parkinson's disease, obsessive-compulsive disorder, essential tremor, addicti

204 Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritual

205 fully to investigate substance addiction and obsessive-compulsive disorder, in a potentially new spec

206 ith several psychiatric disorders, including obsessive-compulsive disorder, major depressive disorder

207 ders, particularly behavioral addictions and obsessive-compulsive disorder, may be due to neurochemic

208 in lOFC, which is known to be hyperactive in obsessive-compulsive disorder, may be responsible for im

209 92; post-traumatic stress disorder, n = 91; obsessive-compulsive disorder, n = 92) alongside n = 201

210 panic disorder with or without agoraphobia, obsessive-compulsive disorder, or posttraumatic stress d

211 t agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, or social anxiety disorde

212 t/outpatient diagnoses of anxiety disorders, obsessive-compulsive disorder, posttraumatic stress diso

213 ntion should be paid to anxiety, depression, obsessive-compulsive disorder, psychosis, personality di

214 isorders, with higher levels associated with obsessive-compulsive disorder, schizophrenia, and anxiet

215 ility of anxiety, major depressive disorder, obsessive-compulsive disorder, schizophrenia, and Parkin

216 essive-compulsive spectrum disorders such as obsessive-compulsive disorder, Tourette's syndrome, path

217 keeping with the model of habit formation in obsessive-compulsive disorder, we hypothesized that this

218 utic interventions alone, at least in severe obsessive-compulsive disorder.

219 al intervention had been used in adults with obsessive-compulsive disorder.

220 nding the neural mechanisms of extinction in obsessive-compulsive disorder.

221 possibly related to depression, anxiety, and obsessive-compulsive disorder.

222 amental mechanism underlying compulsivity in obsessive-compulsive disorder.

223 lar disorder, major depressive disorder, and obsessive-compulsive disorder.

224 gulation of behaviour and habit formation in obsessive-compulsive disorder.

225 nvolved in the modulation of compulsivity in obsessive-compulsive disorder.

226 ereotyped behaviours are typical symptoms of obsessive-compulsive disorder.

227 nd artificial (methamphetamine) rewards, and obsessive-compulsive disorder.

228 the expense of goal-directed performance in obsessive-compulsive disorder.

229 mptoms in patients suffering from refractory obsessive-compulsive disorder.

230 n psychiatric disorders, such as phobias and obsessive-compulsive disorder.

231 otein 3 (SAPAP3)-null mice, a model of human obsessive-compulsive disorder.

232 ic disorder, agoraphobia, social phobia, and obsessive-compulsive disorder.

233 ctive for patients with treatment-refractory obsessive-compulsive disorder.

234 inical outcome of deep brain stimulation for obsessive-compulsive disorder.

235 ion, as well as a new clinical indication in obsessive-compulsive disorder.

236 form noninvasive neuromodulation targets for obsessive-compulsive disorder.

237 been associated with Tourette's syndrome and obsessive-compulsive disorder.

238 ome, dementia, alcohol-induced delusions and obsessive-compulsive disorder.

239 -13) for depressive disorders; 9% (7-10) for obsessive-compulsive disorder; 5% (3-6) for bipolar diso

240 al phobia, specific phobia, agoraphobia, and obsessive-compulsive disorder; these dimensional scores

241 e and resistant to extinction as observed in obsessive compulsive disorders (OCD).

242 Excess guilt proneness might be relevant to obsessive compulsive disorders.

243 of goal-directed behavioural control such as obsessive-compulsive disorders or addictions.

244 pression, fragile X syndrome (FXS), anxiety, obsessive-compulsive disorders, and levodopa induced dys

245 Trichotillomania and trichophagia are obsessive-compulsive disorders, and therefore patients w

246 ting the alternative choice option and their obsessive-compulsive drinking habits.

247 l Anxiety Scale for Children, and Children's Obsessive-Compulsive Impact Scale-Parent Version.

248 Scores on the Obsessive-Compulsive Inventory-Revised, the Dysmorphic C

249 Obsessive compulsive (OC) symptoms involve excessive inf

250 (PG) has been variously conceptualized as an obsessive-compulsive (OC) spectrum disorder or as an add

251 ween obsessive-compulsive disorder (OCD) and obsessive-compulsive personality disorder (OCPD) has lon

252 showed a significantly higher prominence of obsessive-compulsive personality disorder (OCPD) in the

253 Obsessive-compulsive personality disorder was negatively

254 severity, including the modified Yale-Brown Obsessive Compulsive Scale (NE-YBOCS); total scores rang

255 (QOL) was quantified based on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the impact of co

256 ed by the change in scores on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) from baseline until

257 ished, one with level I evidence (Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score improved 37% d

258 a primary diagnosis of OCD and a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 16 or highe

259 The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) to measure OCD sever

260 reatment was determined using the Yale-Brown Obsessive Compulsive Scale (YBOCS), and the primary effi

261 obsessionality, assessed with the Yale-Brown Obsessive Compulsive Scale (YBOCS).

262 oup and changes in the Children's Yale-Brown Obsessive Compulsive Scale and Clinical Global Impressio

263 Children's Yale-Brown Obsessive Compulsive Scale at randomization, biweekly, m

264 B-CBT and FB-RT on the Children's Yale-Brown Obsessive Compulsive Scale at week 14 was 0.84 (95% CI,

265 dex and a modified version of the Yale-Brown Obsessive Compulsive Scale for hypochondriasis (H-YBOCS-

266 The Yale-Brown Obsessive Compulsive Scale measure of distress associate

267 ntly decreased OCD symptoms (mean Yale-Brown Obsessive Compulsive Scale reduction 33%, 40% full respo

268 treatment-refractory OCD (5 men; Yale-Brown Obsessive Compulsive Scale score >32) entered double-bli

269 .66 [0.03]; corresponding to mean Yale-Brown Obsessive Compulsive Scale score change, -60% [19] vs -1

270 ere responders (>=35% decrease of Yale-Brown Obsessive Compulsive Scale score).

271 ure as measured by changes in the Yale-Brown Obsessive Compulsive Scale score.

272 iveness was assessed by change in Yale-Brown Obsessive Compulsive Scale scores.

273 ssessment point on the Children's Yale-Brown Obsessive Compulsive Scale total score (estimate, -2.31,

274 ficant declines in the Children's Yale-Brown Obsessive Compulsive Scale total score and Clinical Glob

275 diagnosis of OCD and a Children's Yale-Brown Obsessive Compulsive Scale total score of 16 or higher.

276 uator-rated continuous Children's Yale-Brown Obsessive Compulsive Scale total score.

277 of 6 or higher on the Children's Yale-Brown Obsessive Compulsive Scale, modified for pervasive devel

278 the primary efficacy measure, the Yale-Brown Obsessive Compulsive Scale, of >/=35% over the 3-year fo

279 OCD symptoms, measured using the Yale-Brown Obsessive Compulsive Scale-Observer-Rated (Y-BOCS-OR) at

280 ompulsions were assessed with the Yale-Brown Obsessive Compulsive Scale.

281 mptom severity as measured by the Yale-Brown Obsessive Compulsive Scale.

282 te to severe OCD (mean Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)=28.2 +/- 3.7), 17 o

283 Scores on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Clinical Glo

284 ments were investigated using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Hamilton Dep

285 moderated the slope of change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) scores across treatm

286 al analog scale (OCD-VAS) and the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) were used to assess

287 ween fear extinction deficits and Yale-Brown Obsessive-Compulsive Scale symptoms in OCD suggest that

288 Scale-Revised, and the Children's Yale-Brown Obsessive-Compulsive Scale).

289 ured with the modified Children's Yale-Brown Obsessive-Compulsive Scale.

290 tients' scores on the Dimensional Yale-Brown Obsessive-Compulsive Scale.

291 tributing to the development and severity of obsessive-compulsive spectrum disorders such as obsessiv

292 useful treatment for patients suffering from obsessive-compulsive spectrum disorders with high impuls

293 A reduction in obsessive-compulsive symptom severity may result not onl

294 4, r=0.55, P=0.042) but not with severity of obsessive compulsive symptoms in OCD.

295 Moreover, by showing that schizophrenia and obsessive-compulsive symptoms could be modeled in animal

296 Adolescents with more severe obsessive-compulsive symptoms may receive more benefits

297 al measures of inattention, social deficits, obsessive-compulsive symptoms, and general adaptive func

298 ding positive urgency, distress intolerance, obsessive-compulsive symptoms, disordered eating, and a

299 an did FBT for participants with more severe obsessive-compulsive symptoms.

300 attention deficits or depressive, manic, or obsessive-compulsive symptoms.